Mativ Boston Consulting Group Matrix
Fully Editable
Tailor To Your Needs In Excel Or Sheets
Professional Design
Trusted, Industry-Standard Templates
Pre-Built
For Quick And Efficient Use
No Expertise Is Needed
Easy To Follow
Mativ Bundle
See the Bigger Picture
Curious where Mativ’s products actually sit—Stars, Cash Cows, Dogs, or Question Marks? This preview teases the shape of the portfolio; buy the full BCG Matrix to get quadrant-by-quadrant placement, data-driven recommendations, and a clear playbook for where to invest, divest, or defend. Get instant access to a ready-to-use Word report and Excel summary that saves you hours and gives the confidence to act fast.
Stars
Advanced filtration media for clean air and e-mobility
High-growth demand from EVs, hyperscale data centers, and tighter air regulations has put advanced filtration media in the slipstream; global BEV sales passed 14 million in 2023 and filtration demand rose further into 2024. Mativ’s engineered media and application depth give it a leadership edge in specs and qualification. It needs sustained capex, pilot lines, and marketing to defend and grow share — feed it to graduate into outsized cash.
Healthcare and wound-care performance materials
Healthcare customers are sticky and regulatory barriers are high, with the global wound-care market growing at roughly a 5% CAGR and on track for >$20B by 2028; Mativ’s specialty substrates and coatings fit high-value, certified applications (IVD, dressings, surgical) and command premium pricing. These programs absorb working capital and multi-million-dollar validation cycles (12–24 months), so continue investing in capacity, quality systems, and co-development with top OEMs.
High-performance release liners for tech and medical
Precision liners for tapes, wearables and medical devices align with multi-year secular growth (wearable sensors market CAGR ~8% to 2028), and Mativ’s coating know-how and reliability make it a go-to spec partner; volumes ramp fast when customers scale, often multiplying by 3x–5x in launch years. Application labs and rapid sampling shorten qualification cycles, locking in first-to-line positions and recurring revenue.
Sustainable premium packaging substrates
Brands demand plastic reduction and curbside recyclability, yesterday; fiber-based, high-appearance substrates with functional barrier options are meeting that need in 2024 and winning shelf share as market growth accelerates. Early movers capture premium listings and pricing; prioritize barrier innovation, enhanced print performance, and regional converting partnerships to scale fast.
- Market trend: 2024 demand spike for recyclable fiber substrates
- Focus: barrier R&D, print quality, regional converting
- Strategy: early investment = shelf share and pricing power
Filtration and protection for electronics and cleanrooms
Semiconductor and advanced manufacturing have tightened particulate and EHS specs, boosting demand for high-performance filtration media and specialty nonwovens. These products can command 15–35% price premiums; qualification cycles typically run 12–24 months and create sticky revenue. Continue building credibility through trials, audits, and global supply assurance as 2024 fab capex expansions sustain demand.
EVs, hyperscale data centers and healthcare drove premium filtration demand in 2024
EVs, hyperscale data centers, healthcare and sustainability drove 2024 demand for Mativ stars; BEV sales hit 14M in 2023 and filtration demand rose further into 2024. These businesses earn 15–35% premiums, have 12–24 month qualifications, and require sustained capex and pilot lines to scale. Sticky healthcare and tape programs yield recurring revenue but tie up working capital. Early shelf-share wins and regional converting speed commercialization.
| Segment | Key 2024 metric | Outlook | Action |
|---|---|---|---|
| Filtration | 15–35% premium | fab capex up | capex, audits |
| Healthcare | Wound-care >$20B by 2028 | 5% CAGR | validation, quality |
What is included in the product
Detailed Word Document
Concise BCG-style review of Mativ's units—Stars, Cash Cows, Question Marks, Dogs—with investment recommendations and trend context.
Customizable Excel Spreadsheet
One-page Mativ BCG Matrix pinpoints growth and cash cows fast, easing portfolio decisions for founders and CFOs.
Cash Cows
Industrial release liners for tapes and labels
Industrial release liners for tapes and labels are classic cash cows: mature, high-share franchises that generate steady free cash in a global release-liner market valued around US$3.8 billion in 2024 with low-single-digit CAGR. Operational excellence and tight yield management, not bold R&D, drive profit; sustaining engineering and light product refreshes preserve 15–25% margins. Milk with discipline, automate where possible, and fiercely defend core accounts.
HVAC and industrial replacement filtration
HVAC and industrial replacement filtration delivers steady recurring revenue from replacement cycles typically every 3–12 months and broad distribution networks, making it a dependable earner; the global air filtration market was estimated near $11 billion in 2024 with mid-single-digit growth. Volumes are predictable, so price management and SKU rationalization are primary profit levers. Maintain service levels, optimize product mix, and reinvest only for automation and efficiency gains to protect margins.
Specialty papers for labels and graphics
Specialty papers for labels and graphics occupy stable niches with entrenched specifications and long-standing customers, delivering cash reliability; in 2024 this segment contributed a substantial portion of Mativ’s cash flow (net sales approx. $2.1B companywide in 2024). Product differentiation is defensible but limits growth, so priorities must be cost, consistent quality, and tight lead times. Harvest excess cash and reallocate to higher-growth platforms and R&D to drive future expansion.
Tobacco-related engineered papers
Tobacco-related engineered papers remain cash cows for Mativ: large global share positions generate steady free cash flow despite mid-to-low single-digit volume declines in 2023–24, as processes are highly optimized and largely depreciated. Long-term pricing and multi-year contracts cushion volume drift, enabling reduced maintenance capex and strong margin protection. Surplus cash is prioritized for next-gen materials and targeted R&D to offset portfolio secular decline.
- Low-to-negative growth: mid-single-digit volume decline (2023–24)
- High cash conversion: optimized, well-depreciated assets
- Pricing/contracts: revenue stability vs volume risk
- Capex: managed down to preserve margins
- Capital allocation: surplus to next-gen materials/R&D
Protective films and functional coatings for industry
Protective films and functional coatings are cash cows for Mativ: a large installed base keeps orders steady in a mature market (industry growth ~3% CAGR in 2024), differentiation rests on process know-how and consistency, and incremental innovation preserves price premiums and loyalty; focus is on harvesting cash with tight operations and selective customer upgrades.
- installed base: recurring demand
- 2024 industry growth ~3% CAGR
- value from process consistency
- incremental innovation = premium retention
- strategy: run for cash, tight ops, select upgrades
Mature franchises: steady cash 15–25% margins—harvest, reinvest
Mativ cash cows (2024): mature franchises (release liners $3.8B market, HVAC filtration ~$11B, specialty papers supporting company net sales ~$2.1B) generate steady free cash with 15–25% operating margins, low-to-mid single-digit market growth, and high cash conversion; prioritize disciplined harvest, automation, SKU rationalization, and targeted reinvestment into next-gen R&D.
| Segment | 2024 market | Growth | Op margin |
|---|---|---|---|
| Release liners | $3.8B | low-SD | 15–25% |
| HVAC filtration | $11B | mid-SD | 15–25% |
What You See Is What You Get
Mativ BCG Matrix
The file you’re previewing is the exact Mativ BCG Matrix document you’ll receive after purchase. No watermarks, no demo copy—just a fully formatted, analysis-ready report built for clarity. After buying, the same file is available for immediate download and editing. It’s designed by strategy pros to plug straight into your planning, presentations, or client work without surprises.
Dogs
Commoditized print and commodity paper SKUs
Commoditized print and commodity paper SKUs sit in a low-growth, low-share quadrant where price-led competition drags overall segment profitability. Minimal switching costs accelerate churn and margins erode rapidly, making profitability fragile. Turnarounds demand high CAPEX and rarely deliver lasting uplift. Exit or consolidate these SKUs to free up production lines and commercial mindshare.
Non-differentiated packaging grades
Where barriers are thin and buyers shop purely on price, differentiated value collapses and gross margins can fall below 5%, especially in commodity packaging. Capacity gluts amplify pain as utilization drops and inventory days often stretch to 60–90 days, tying up cash. Frequent SKU changeovers add hours of downtime and thousands of dollars per run, eroding returns. Prune aggressively or divest non-strategic, low-margin grades.
Legacy healthcare SKUs displaced by newer tech
Legacy healthcare SKUs are being displaced by breathable, thinner, and sustainable alternatives that captured rapid share in 2023–24; validation to recapture customers typically requires 12–18 months and six-figure investments per SKU, making reclamation uneconomical. Revenues now trickle and divert R&D and commercial teams; sunset programs and redeploy resources into growth platforms where Mativ’s ~$2.0B topline can scale faster.
Small regional liner offerings without scale
Small regional liner offerings without scale serve niche geographies where subscale volumes fail to cover fixed costs; 2024 industry reviews show over 50% of such routes operate below breakeven and margins compress to mid-single digits. Competitors localize faster and cheaper, triggering price wars that further erode profitability. Consolidate SKUs or exit markets cleanly to stop losses.
- focus: cut unprofitable lanes
- metrics: route breakeven rate, utilization
- action: SKU consolidation or clean exit
Over-customized one-off industrial solutions
Engineering-heavy, one-off industrial projects consume capacity and cash, delivering low repeat orders and limited account scalability; in 2024 many OEMs reported single-job work tying up >30% of engineering bandwidth.
Opportunity cost is the silent killer—time spent on bespoke builds displaces scalable product development and aftermarket revenue; say no more often, standardize or stop.
- Tag: engineering-heavy
- Tag: low-repeat
- Tag: capacity-drain
- Tag: opportunity-cost
- Tag: standardize-or-stop
Commoditized SKUs crush margins under 5%, routes and CAPEX bleeding cash
Commoditized SKUs sit in low-growth, low-share roles with price-led competition eroding margins; gross margins often fall below 5% and inventory stretches 60–90 days. Turnarounds need six-figure CAPEX per SKU and rarely recover share. Over 50% of small routes ran below breakeven in 2024; bespoke projects can tie up >30% engineering bandwidth.
| Metric | 2024 |
|---|---|
| Mativ topline | $2.0B |
| Gross margin (commodities) | <5% |
| Inventory days | 60–90 |
| CAPEX per SKU | $100k+ |
| Routes below breakeven | >50% |
| Eng bandwidth on bespoke | >30% |
Question Marks
Bio-based, PFAS-alternative barrier coatings
Regulatory tailwinds are strong—EU 2024 PFAS restriction moves and US EPA actions plus major CPGs (Nestlé, Unilever, PepsiCo) committing PFAS phase-outs by 2025–2030 are accelerating demand; tech race is wide open. Early pilots show promise with 10–20 SKUs reporting parity on grease/oxygen barriers, but scale economics unproven—need >90% line-speed retention and cost within 10–20% of PFAS routes. If performance and cost land, this could flip to a Star; prioritize expanded trials with anchor CPGs and kill fast if durability lags.
Compostable and recyclable flexible materials
Brands demand compostable and recyclable flexible materials but infrastructure and standards vary by region, with EN 13432, ASTM D6400 and ISO 17088 guiding claims; over 50% of CPG brands listed sustainability requirements in 2024 RFPs. Adoption curves depend on achieving performance parity and price within single-digit premium ranges to match incumbents. Securing a few flagship conversions creates momentum and accelerates category adoption. Prioritize certification, end-of-life testing and converter alliances to de-risk supply chains and claims.
Water and wastewater microfiltration media
Water and wastewater microfiltration media sits as a Question Mark: global need is clear in 2024 amid aging infrastructure, but municipal procurement cycles remain slow (typically 18–24 months) and specs are exacting, making incumbents sticky.
A differentiated performance-to-cost claim — e.g., demonstrated OPEX reductions of up to 15% and longer media life — could unlock share.
Fund targeted pilots with municipalities and industrials (pilot budgets ~100k–300k) to prove lifetime value and accelerate adoption.
E-mobility thermal and acoustic management substrates
Mativ’s e-mobility thermal and acoustic substrates sit in Question Marks: EV platforms are still standardizing material stacks and OEM approvals typically take 12–24 months, but once approved access is sticky; if Mativ meets weight, safety and cost targets, addressable revenue can scale quickly as EV content per vehicle rises—EV penetration reached about 18% of new car sales in 2024.
- Co-develop with Tier 1s to shorten approval cycles
- Secure multi-year nominations to lock recurring volumes
- Target weight/safety/cost parity to enable rapid growth
Functional papers for electronics and smart packaging
Functional papers for electronics and smart packaging show cool concepts but fragmented demand; pilot-to-scale conversion remained under 10% in 2024, so they need killer use-cases that scale beyond pilots. If printability, barrier performance and conductivity align, adoption can break out; keep a small, sharp team with milestone-gate funding to de-risk commercialization.
- Use-case-first
- Printability+barrier+conductivity
- Small team, milestone funding
- Scale beyond pilots
2024: PFAS bans boost replacements; compostable flex needs certs + single-digit premium; EVs 18%
Strong 2024 regulatory and CPG phase-out signals boost PFAS-replacement upside; pilots show SKU parity but cost/scale unproven. Compostable flex needs certification and single-digit premium pricing to convert demand. Municipal microfiltration faces 18–24 month procurement cycles; e-mobility approvals 12–24 months with EVs at 18% new sales. Functional papers <10% pilot-to-scale in 2024—need killer use-cases.
| Segment | 2024 signal | Key metric | Priority action |
|---|---|---|---|
| PFAS substitutes | EU restrictions, CPG phase-outs | 10–20 SKUs parity | Scale trials |
| Compostable flex | 50% CPG RFPs | single-digit premium | Certify+converter deals |
| Microfiltration | Aging infra demand | 18–24 mo procurement | Pilot municipalities |
| E-mobility | 18% EV new sales | 12–24 mo approvals | Co-develop Tier1s |
| Functional papers | Fragmented pilots | <10% scale | Use-case focus |